Malta - English - Medicines Authority

boehringer ingelheim ellas a.e. ellinikou 2, 167 77 elliniko, athens, greece - ambroxol hydrochloride - syrup - ambroxol hydrochloride 15 mg/5ml - cough and cold preparations

Malta - English - Medicines Authority

boehringer ingelheim ellas a.e. ellinikou 2, 167 77 elliniko, athens, greece - ambroxol hydrochloride - tablet - ambroxol hydrochloride 30 mg - cough and cold preparations

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetine - diabetic neuropathies - psychoanaleptics, - treatment of diabetic peripheral neuropathic pain in adults.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - afatinib - carcinoma, non-small-cell lung - antineoplastic agents - giotrif as monotherapy is indicated for the treatment ofepidermal growth factor receptor (egfr) tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin, linagliptin - diabetes mellitus, type 2 - drugs used in diabetes - glyxambi, fixed dose combination of empagliflozin and linagliptin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:to improve glycaemic control when metformin and/or sulphonylurea (su) and one of the monocomponents of glyxambi do not provide adequate glycaemic control;when already being treated with the free combination of empagliflozin and linagliptin.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - drugs used in diabetes - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1. of the annex.heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease. 

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - nintedanib - idiopathic pulmonary fibrosis - antineoplastic agents - ofev is indicated in adults for the treatment of idiopathic pulmonary fibrosis (ipf).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - nintedanib - carcinoma, non-small-cell lung - antineoplastic agents - vargatef is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (nsclc) of adenocarcinoma tumour histology after first line chemotherapy.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - linagliptin - diabetes mellitus, type 2 - drugs used in diabetes - trajenta is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults:as monotherapyin patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.as combination therapyin combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control.in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control.in combination with insulin with or without metformin, when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim limited - pimobendan - solution for injection - cardio vascular - dogs